Design, synthesis, and evaluation of curcumin-derived arylheptanoids for glioblastoma and neuroblastoma cytotoxicity

Bioorganic and Medicinal Chemistry Letters

Volumn 23, Issue 24, 2013, Pages 6874-6878

  Campos, Catherine A ^a   Gianino, Joseph B ^a   Bailey, Barbara J ^b   Baluyut, Mary E ^b   Wiek, Constanze ^d   Hanenberg, Helmut ^b,c,d   Shannon, Harlan E ^b   Pollok, Karen E ^b   Ashfeld, Brandon L ^a  

^a UNIVERSITY OF NOTRE DAME   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Arylheptanoids; Curcumin; Glioblastoma; Neuroblastoma; Relay catalysis

Indexed keywords

CURCUMIN; CURCUMIN DERIVATIVE; HEPTANE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DESIGN; DRUG SYNTHESIS; GLIOBLASTOMA; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; NEUROBLASTOMA;

ARYLHEPTANOIDS; CURCUMIN; GLIOBLASTOMA; NEUROBLASTOMA; RELAY CATALYSIS;

ANTINEOPLASTIC AGENTS; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; CURCUMIN; DRUG DESIGN; GLIOBLASTOMA; HEMATOPOIETIC STEM CELLS; HUMANS; NEUROBLASTOMA; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84888871917     PISSN: 0960894X     EISSN: 14643405     Source Type: Journal    
DOI: 10.1016/j.bmcl.2013.09.095     Document Type: Article

References (57)

1. Surveillance, Epidemiology, and End Results (SEER) Program and the National Center for Health Statistics. http://seer.cancer.gov/statfacts/html/ brain.html.
2. L.A.G. Ries, D. Melbert, M. Krapcho, A. Mariotto, B.A. Miller, E.J. Feuer, L. Clegg, M.J. Horner, N. Howlader, M.P. Eisner, M. Reichman, and B.K. Edwards SEER Cancer Statistics Review 1975-2004; National Institutes of Health 2007 Bethesda, MD National Cancer Institute
3. C. Balmaceda, D. Peereboom, S. Pannullo, Y.K.K. Cheung, P.G. Fisher, J. Alavi, M. Sisti, J. Chen, and R.L. Fine Cancer 112 2008 1139
4. E. Galanis, K.A. Jaeckle, M.J. Maurer, J.M. Reid, M.M. Ames, J.S. Hardwick, J.F. Reilly, A. Loboda, M. Nebozhyn, V.R. Fantin, V.M. Richon, B. Scheithauer, C. Giannini, P.J. Flynn, D.F. Moore Jr., J. Zwiebel, and J.C. Buckner J. Clin. Oncol. 27 2009 2052
5. D.K. Agrawal, and P.K. Mishra Med. Res. Rev. 30 2010 818
6. P. Anand, S.G. Thomas, A.B. Kunnumakkara, C. Sundaram, K.B. Harikumar, B. Sung, S.T. Tharakan, K. Misra, I.K. Priyadarsini, K.N. Rajasekharan, and B.B. Aggarwal Biochem. Pharmacol. 76 2008 1590
7. A. Goel, A.B. Kunnumakkara, and B.B. Aggarwal Biochem. Pharmacol. 75 2008 787
8. A.J. Ruby, G. Kuttan, K. Dinesh Babu, K.N. Rajasekharan, and R. Kuttan Cancer Lett. 94 1995 79
9. J.A. Bush, K.J.J. Cheung Jr, and G. Li Exp. Cell. Res. 271 2001 305
10. M.C.M. Jiang, H.F.H. Yang-Yen, J.J.J. Yen, and J.K.J. Lin Nutr. Cancer 26 1996 111
11. K. Nakamura, Y. Yasunaga, T. Segawa, D. Ko, J.W. Moul, S. Srivastava, and J.S. Rhim Int. J. Oncol. 21 2002 825
12. C. Ramachandran, S. Rodriguez, R. Ramachandran, P.K. Raveendran Nair, H. Fonseca, Z. Khatib, E. Escalon, and S.J. Melnick Anticancer Res. 25 2005 3293
13. R.A. Sharma, A.J. Gescher, and W.P. Steward Eur. J. Cancer 2005 1955 41
14. K.M. Dhandapani, V.B. Mahesh, and D.W. Brann J. Neurochem. 102 2007 522
15. C. Freudlsperger, J. Greten, and U. Schumacker Anticancer Res. 28 2008 209
16. A. Liontas, and H. Yeger Anticancer Res. 24 2009 987
17. M.-C. Perry, M. Demeule, A. Régina, R. Moumdjian, and R. Béliveau Mol. Nutr. Food Res. 54 2010 1192
18. S. Purkayastha, A. Berliner, S.S. Fernando, B. Ranasinghe, I. Ray, H. Tariq, and P. Banerjee Brain Res. 1266 2009 130
19. C. Senft, M. Polacin, M. Priester, V. Seifert, D. Kögel, and J. Weissenberger BMC Cancer 10 2010 491
20. For selected references describing modification of the 1,3-dicarbonyl region of curcumin, see: (a) L. Lin, Q. Shi, A.K. Nyarko, K.F. Bastow, C.-C. Wu, C.-Y. Su, C.C.Y. Shih, and K.-H. Lee J. Med. Chem. 49 2006 3963
21. K.-L. Tan, S.-B. Koh, R.P.-L. Ee, M. Khan, and M.-L. Go ChemMedChem 7 2012 1567
22. M. Yamaguchi, T.W. Moore, A. Sun, J.P. Snyder, and M. Shoji Integr. Biol. 4 2012 905
23. Y. Zuo, J. Huang, B. Zhou, S. Wang, W. Shao, C. Zhu, L. Lin, G. Wen, H. Wang, J. Du, and X. Bu Eur. J. Med. Chem. 55 2012 346
24. H. Ohori, H. Yamakoshi, M. Tomizawa, M. Shibuya, Y. Kakudo, A. Takahashi, S. Takahashi, S. Kato, T. Suzuki, C. Ishioka, Y. Iwabuchi, and H. Shibata Mol. Cancer Ther. 5 2006 2563
25. Q. Zhang, Y. Zhong, L.-N. Yan, X. Sun, T. Gong, and Z.-R. Zhang Biorg. Med Chem. Lett. 21 2011 1010
26. S. Batie, J.H. Lee, R.A. Jama, D.O. Browder, L.A. Montano, C.C. Huynh, L.M. Marcus, D.G. Tsosie, Z. Mohammed, V. Trang, P.A. Marshall, P.W. Jurutka, and C.E. Wagner Bioorg. Med. Chem. 21 2013 693
27. C.A. Campos, J.B. Gianino, D.M. Pinkerton, and B.L. Ashfeld Org. Lett. 13 2011 5680
28. J.B. Gianino, and B.L. Ashfeld J. Am. Chem. Soc. 134 2012 18217
29. C.A. Campos, J.B. Gianino, and B.L. Ashfeld Org. Lett. 15 2013 2656
30. A.J. Lepore, D.M. Pinkerton, and B.L. Ashfeld Adv. Synth. Catal. 355 2013 1500
31. P. Anastas, and M. Kirchhoff Acc. Chem. Res. 35 2002 686
32. F.-X. Felpin, and E. Fouquet ChemSusChem 1 2008 718
33. K.C. Nicolaou, D.J. Edmonds, and P.G. Bulger Angew. Chem., Int. Ed. 45 2006 7134
34. L.F. Tietze Chem. Rev. 96 1996 115
35. L.F. Tietze, and U. Beifuss Angew. Chem., Int. Ed. 32 1993 131
36. For recent work on titanocene-catalyzed metallations and related processes, see: (a) L.M. Fleury, and B.L. Ashfeld Org. Lett. 11 2009 5670
37. L.M. Fleury, and B.L. Ashfeld Tetrahedron Lett. 51 2010 2427
38. L.M. Fleury, J.B. Gianino, and B.L. Ashfeld Tetrahedron Lett. 53 2012 5376
39. L.M. Fleury, A.D. Kosal, J.T. Masters, and B.L. Ashfeld J. Org. Chem. 2012 ASAP Article
40. A.D. Kosal, and B.L. Ashfeld Org. Lett. 12 2010 44
41. E.E. Wilson, A.G. Oliver, R.P. Hughes, and B.L. Ashfeld Organometallics 30 2011 5214
42. L. Boulard, S. BouzBouz, J. Cossy, X. Franck, and B. Figadère Tetrahedron Lett. 45 2004 6603
43. H. Hanawa, D. Uraguchi, S. Konishi, T. Hashimoto, and K. Maruoka Chem. Eur. J. 9 2003 4405
44. D.L. Usanov, and H. Yamamoto J. Am. Chem. Soc. 133 2011 1286
45. A. Fürstner, and K. Radkowski Chem. Commun. 2002 2182
46. K. Micoine, and A. Fürstner J. Am. Chem. Soc. 132 2010 14064
47. B.M. Trost, and Z.T. Ball J. Am. Chem. Soc. 125 2003 30
48. B.M. Trost, Z.T. Ball, and T. Jöge J. Am. Chem. Soc. 124 2002 7922
49. V. Rauniyar, and D.G. Hall J. Org. Chem. 74 2009 4236
50. E.J. Corey, and P.L. Fuchs Tetrahedron Lett. 13 1972 3769
51. H.-B. Chen, J. Yin, Y. Wang, and J. Pei Org. Lett. 10 2008 3113
52. T. Saitoh, T. Oyama, K. Sakurai, Y. Niimura, M. Hinata, Y. Horiguchi, J. Toda, and T. Sano Chem. Pharm. Bull. 44 1996 956
53. E.J. Corey, R.K. Bakshi, S. Shibata, C.P. Chen, and V.K. Singh J. Am. Chem. Soc. 109 1987 7925
54. C.J. Helal, P.A. Magriotis, and E.J. Corey J. Am. Chem. Soc. 118 1996 10938
55. M.H. Oliver, N.K. Harrison, J.E. Bishop, P.J. Cole, and G.J. Laurent J. Cell Sci. 92 1989 513
56. A. Petitjean, E. Mathe, S. Kato, C. Ishioka, S.V. Tavtigian, P. Hainaut, and M. Olivier Hum. Mutat. 28 2007 622
57. S. Cai, H. Wang, A.R. Baluyut, A. Ernstberger, B. Juliar, A.L. Sinn, L.D. Mayo, W.S. Goebel, and K.E. Pollok Clin. Cancer Res. 8 2011 2195